Back to results
US 2026/0229306 A1Published application
Method for detecting fetal copy number variations based on virtual positive and negative data
AssigneeGenomecare Co., Ltd
InventorsSunshin KIM, Krishna Prasad ADHIKARI, Jae Hwan JEONG, Gyeong In OH
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for detecting fetal copy number variations (CNVs) based on synthetic positive and negative data, as well as a computer-readable medium recording a program applied to perform this method. Accordingly, the present invention allows for non-invasive prenatal diagnosis of fetal CNVs with high sensitivity and specificity.
Claims15
A method for detecting fetal copy number variations, comprising:
- obtaining sequence information (read) of a plurality of nucleic acid fragments obtained from a biological sample of a pregnant woman with a normal fetus;
- mapping the obtained sequence information to a human reference genome and aligning the sequence information of the nucleic acid fragments to a chromosome;
- calculating the read count (RC), fetal DNA fraction (fetal fraction:
- FF), and GC content of the sequence information of the nucleic acid fragments in the target chromosome in a normal fetus, based on the sequence information of the nucleic acid fragments aligned to the chromosome;
- producing synthetic normal data from normal data based on the read count and fetal DNA fraction in the target chromosome in a normal fetus, wherein the normal data is the read count in the target chromosome site in a normal fetus;
- producing synthetic positive data from the synthetic normal data, wherein the synthetic positive data is the read count in the target chromosome site in a fetus with copy number variations;
- establishing a copy number variation discrimination model from the produced synthetic normal data and synthetic positive data;
- and
- detecting copy number variations of a test sample using the copy number variation discrimination model.
6 more elements
A computer-readable medium recording a program applied to perform that performs the steps of:
- obtaining sequence information (read) of a plurality of nucleic acid fragments obtained from a biological sample of a pregnant woman with a normal fetus;
- mapping the obtained sequence information to a human reference genome and aligning the sequence information of the nucleic acid fragments to a chromosome;
- calculating the read count (RC), fetal DNA fraction (fetal fraction:
- FF), and GC content of the sequence information of the nucleic acid fragments in the target chromosome in a normal fetus, based on the sequence information of the nucleic acid fragments aligned to the chromosome;
- producing synthetic normal data from normal data based on the read count and fetal DNA fraction in the target chromosome in a normal fetus, wherein the normal data is the read count in the target chromosome site in a normal fetus;
- producing synthetic positive data from the synthetic normal data, wherein the synthetic positive data is the read count in the target chromosome site in a fetus with copy number variations;
- establishing a copy number variation discrimination model from the produced synthetic normal data and synthetic positive data;
- and
- detecting copy number variations of a test sample using the copy number variation discrimination model.
6 more elements
Dependencies are inferred from the claim text.